Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Jaeschke

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman JaeschkeHertzel Gerstein, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
SPRINT trial and blood pressure treatment. Dr. Gordon Guyatt in an interview with Dr. Roman JaeschkeGordon Guyatt, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2016
VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3Mark Crowther, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2016
Treatment of asthma: predicting the future of atopic disease treatment Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 2Paul O'Byrne, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|December 2, 2016
Safety of long‑acting ß2‑agonists: current state of knowledge. Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 2Paul O'Byrne, Roman Jaeschke
Chest|August 11, 2006
Resource allocation issues and clinical practice guidelinesRoman Jaeschke, Jan Brozek
Saudi Medical Journal|June 19, 2002
Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease undergoing surgery [corrected]Abdulaziz S Aldawood, Roman Jaeschke
Polish Archives of Internal Medicine|April 6, 2017
Treatment of hypertension: When to start? What is the target? Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 2Franz H Messerli, Roman Jaeschke
JAMA|June 11, 2009
Living with uncertainty in the intensive care unit: should patients with sepsis be treated with steroids?Roman Jaeschke, Derek C Angus
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
Do not consider amiodarone, give it! Comment on antiarrhythmic drugs for shock‑refractory ventricular fibrillation or pulseless ventricular tachycardiaAndrew E Gibson, Roman Jaeschke
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman JaeschkeHertzel Gerstein, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
SPRINT trial and blood pressure treatment. Dr. Gordon Guyatt in an interview with Dr. Roman JaeschkeGordon Guyatt, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2016
VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3Mark Crowther, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2016
Treatment of asthma: predicting the future of atopic disease treatment Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 2Paul O'Byrne, Roman Jaeschke
Polskie Archiwum Medycyny Wewnetrznej|December 2, 2016
Safety of long‑acting ß2‑agonists: current state of knowledge. Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 2Paul O'Byrne, Roman Jaeschke
Chest|August 11, 2006
Resource allocation issues and clinical practice guidelinesRoman Jaeschke, Jan Brozek
Saudi Medical Journal|June 19, 2002
Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease undergoing surgery [corrected]Abdulaziz S Aldawood, Roman Jaeschke
Polish Archives of Internal Medicine|April 6, 2017
Treatment of hypertension: When to start? What is the target? Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 2Franz H Messerli, Roman Jaeschke
JAMA|June 11, 2009
Living with uncertainty in the intensive care unit: should patients with sepsis be treated with steroids?Roman Jaeschke, Derek C Angus
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
Do not consider amiodarone, give it! Comment on antiarrhythmic drugs for shock‑refractory ventricular fibrillation or pulseless ventricular tachycardiaAndrew E Gibson, Roman Jaeschke
Pageof 16